PORE Trademark

Trademark Overview

On Wednesday, August 19, 2015, a trademark application was filed for PORE with the United States Patent and Trademark Office. The USPTO has given the PORE trademark a serial number of 86729373. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 20, 2023. This trademark is owned by Karyopharm Therapeutics Inc.. The PORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing an internet website portal in the field of pharmaceutical research that allows for users to conduct confidential communications regarding proposed clinical trials
pore

General Information

Serial Number86729373
Word MarkPORE
Filing DateWednesday, August 19, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 20, 2023
Registration Number5042653
Registration DateTuesday, September 13, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2016

Trademark Statements

Goods and ServicesProviding an internet website portal in the field of pharmaceutical research that allows for users to conduct confidential communications regarding proposed clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 24, 2015
Primary Code042
First Use Anywhere DateThursday, July 9, 2015
First Use In Commerce DateThursday, July 9, 2015

Trademark Owner History

Party NameKaryopharm Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02459

Trademark Events

Event DateEvent Description
Thursday, December 3, 2015ASSIGNED TO EXAMINER
Monday, August 24, 2015NEW APPLICATION ENTERED
Monday, August 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 4, 2015EXAMINER'S AMENDMENT ENTERED
Friday, December 4, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, December 4, 2015EXAMINERS AMENDMENT E-MAILED
Friday, December 4, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 20, 2016TEAS STATEMENT OF USE RECEIVED
Monday, December 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 23, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2016REGISTERED-PRINCIPAL REGISTER
Monday, June 20, 2016SOU TEAS EXTENSION RECEIVED
Monday, June 20, 2016SOU EXTENSION 1 FILED
Monday, June 20, 2016USE AMENDMENT FILED
Saturday, July 23, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 25, 2016SOU EXTENSION 1 GRANTED
Monday, July 25, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 9, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 20, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 20, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 2, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 13, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 6, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 16, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

pore communications confidential conduct regarding proposed trials clinical users allows website